Head to Head Review: BELLUS Health (OTCMKTS:BLUSF) & Flora Growth (NASDAQ:FLGC)

Flora Growth (NASDAQ:FLGCGet Rating) and BELLUS Health (OTCMKTS:BLUSFGet Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, institutional ownership and profitability.

Analyst Ratings

This is a summary of recent ratings for Flora Growth and BELLUS Health, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Flora Growth 0 0 2 0 3.00
BELLUS Health 0 0 0 0 N/A

Flora Growth presently has a consensus target price of $10.75, indicating a potential upside of 726.92%. Given Flora Growth’s higher probable upside, analysts clearly believe Flora Growth is more favorable than BELLUS Health.

Institutional & Insider Ownership

8.1% of Flora Growth shares are owned by institutional investors. 24.2% of BELLUS Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Flora Growth and BELLUS Health’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Flora Growth N/A N/A N/A
BELLUS Health -49,910.34% -48.37% -45.25%

Earnings & Valuation

This table compares Flora Growth and BELLUS Health’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Flora Growth $8.98 million 7.65 -$14.17 million N/A N/A
BELLUS Health $30,000.00 43,863.25 -$7.01 million N/A N/A

BELLUS Health has lower revenue, but higher earnings than Flora Growth.

Summary

Flora Growth beats BELLUS Health on 7 of the 10 factors compared between the two stocks.

About Flora Growth (Get Rating)

Flora Growth Corp., a cannabis company, cultivates, processes, and supplies cannabis products to pharmacies, medical clinics, and cosmetic companies worldwide. It cultivates, processes, and supplies medicinal-grade cannabis oil, and cannabis oil extracts and related products; manufactures and sells skincare and beauty products, such as gel cleanser, eye cream, moisturizer, and hydrating mask; manufactures dermo cosmetic products; and develops and sells pharmaceutical and over-the-counter products, including dietary supplements, phytotherapeutic and nutraceutical products, supplements, and related products. It also manufactures and sells hemp textiles products focuses on servicing the hospitality, medical, and clothing industries on a B2B basis; designs, produces, and supplies juices, chocolate, and chocolate related products to wholesale distributors, pharmacies, supermarkets, and online distributors; and offers and wellness products. The company's brand includes Mambe, Mind Naturals, Almost Virgin, Flora Lab, and Stardog Loungewear. The company was incorporated in 2019 and is headquartered in Toronto, Canada.

About BELLUS Health (Get Rating)

BELLUS Health, Inc. is a biopharmaceutical development company, which engages in the research and development of products that provide health solutions and address critical unmet medical needs. Its products include BLU-5937, KIACTA, AMO-01, and ALZ-801. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.

Receive News & Ratings for Flora Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Flora Growth and related companies with MarketBeat.com's FREE daily email newsletter.